Research

Low levels of antibodies for the S protein of SARS-CoV-2 are associated with a higher risk of death in critical COVID-19 patients

The study, led by CIBERES, included the participation of IDIBAPS and was published in the Journal of Internal Medicine.

From left to right: Antoni Torres, Jesús Bermejo, José María Eiros, Salvador Resino, and Ferrán Barbé.

Related contents